text.skipToContent text.skipToNavigation

Avviso solo per i clienti dell"Indonesia  Visualizza dettagli
Informazioni di contatto per l"assistenza clienti:
pim.indonesia.contact.title2
Layanan Pengaduan Konsumen

(Business Unit Performance Materials, Team di supporto alle vendite)

pim.indonesia.contact.address

Gedung AIA Centrale, Livello 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesia

+62 21 2988 8557

[email protected]

Direktorat Jenderal Perlindungan Konsumen dan Tertib Niaga Kementerian Perdagangan Republik Indonesia
0853 1111 1010

Successo! La tua richiesta è stata inviata al nostro team commerciale.

pim.add.to.wishlist.popup.error

  • /_ui/responsive/common/custom/images/default-supplier-banner-1.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-2.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-3.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-4.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-5.jpg

ARAGEN

Aragen Life Sciences (formerly GVK Biosciences) is a leading Contract Research, Development, and Manufacturing Organization (CDMO) providing end-to-end solutions for global biopharma companies. With over 20 years of experience, Aragen partners with 450+ clients worldwide, offering expertise across small molecules and biologics, from drug discovery to commercialization. Backed by Goldman Sachs, the company operates across 7 sites in India and overseas, including a US biologics campus, with a team of 3,100+ professionals, including 400+ PhDs. Aragen’s renewed brand identity, symbolized by AURA, reflects its values of ambition, resilience, and agility, while its promise, “Together Ahead”, highlights its commitment to driving scientific innovation and improving health outcomes. Positioned in the rapidly growing CDMO market, Aragen continues to expand its capabilities, leveraging India's prominence and its proven expertise.

 

Scarica i documenti

Galleria multimediale

La quantità del prodotto è stata aggiornata.